Hims & Hers Health's (HIMS) Apostrophe business said it's being discontinued, with all existing subscriptions to be canceled as of March 7.
Apostrophe said customers will be able to access provider team and receive support through their patient accounts for the next 30 days, according to a message posted on its website.
Hims & Hers shares were down 2.1% in recent premarket activity Monday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.